Snippet Search

Searching 11,767,396 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 150 matching articles

Results per page:

... intravesical regimen that includes both  mitomycin 
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
Hayne, Dickon; Stockler, Martin; McCombie, Steve P.; Chalasani, Venu; Long, Anne; Martin, Andrew; Sengupta, Shomik; Davis, Ian D.
and BCG. ...
... the effect on intestinal wound healing of  mitomycin 
The optimal starting time of postoperative intraperitoneal mitomycin-C therapy with preserved intestinal wound healing
The optimal starting time of postoperative intraperitoneal mitomycin-C therapy with preserved intestinal wound healing
Uzunkoy, Ali; Bolukbas, Cengiz; Horoz, Mehmet; Bolukbas, Fusun F; Kocyigit, Abdurrahim
-C administered at different times ...
... (25 mg/m2) iv q mo NR EMP (560 mg) daily  mitomycin 
Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group
Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group
Winquist, Eric; Waldron, Tricia; Berry, Scott; Ernst, D Scott; Hotte, Sébastien; Lukka, Himu
C (10 mg/m2) iv q mo Anderström, 1995 [72] ...
... (5-FU), cisplatin, carboplatin,  mitomycin 
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
Budach, W; Hehr, T; Budach, V; Belka, C; Dietz, K
C) were analyzed according to the employed ...
... (N = 8). Eight patients were treated with  mitomycin 
Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia
Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia
Levin, Robert D; Daehler, MaryAnn; Grutsch, James F; Hall, John L; Gupta, Digant; Lis, Christopher G
, which can induce persistent bone marrow ...
... in dimethyl sulfoxide), cisplatin and  mitomycin 
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction
Schulze-Bergkamen, Henning; Fleischer, Binje; Schuchmann, Marcus; Weber, Achim; Weinmann, Arndt; Krammer, Peter H; Galle, Peter R
C from Calbiochem (Schwalbach, Germany), ...
... gemcitabine, irinotecan, melphalan,  mitomycin 
Effects of hypoxia on human cancer cell line chemosensitivity
Effects of hypoxia on human cancer cell line chemosensitivity
Strese, Sara; Fryknäs, Mårten; Larsson, Rolf; Gullbo, Joachim
c, rapamycin, sorafenib, thalidomide, ...
... Background  Mitomycin 
Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study
Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study
Sørensen, Olaf; Andersen, Anders; Olsen, Harald; Alexandr, Kristian; Ekstrøm, Per Olaf; Giercksky, Karl-Erik; Flatmark, Kjersti
C is a chemotherapeutic agent used in the ...
... remarkable advantage of BCG combined with  Mitomycin 
Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies
Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies
Zhu, Shimiao; Tang, Yang; Li, Kai; Shang, Zhiqun; Jiang, Ning; Nian, Xuewu; Sun, Libin; Niu, Yuanjie
C or with interferon α-2b in improving ...
... for sensitivity to oxaliplatin, cisplatin,  mitomycin 
Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer
Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer
Cashin, Peter H; Mahteme, Haile; Graf, Wilhelm; Karlsson, Henning; Larsson, Rolf; Nygren, Peter
C, melphalan, irinotecan, docetaxel, ...
... cytostatic drugs, group IV: HIPEC with  mitomycin 
Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations
Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations
Pelz, Joerg OW; Doerfer, J; Dimmler, A; Hohenberger, W; Meyer, T
C in a concentration of 15 mg/m2 (n = 6), ...
... protects against the DNA-crosslinker,  mitomycin 
Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)
Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)
Damelin, Leonard Howard; Jivan, Rupal; Veale, Robin Bruce; Rousseau, Amanda Louise; Mavri-Damelin, Demetra
C, but is dependent on a metformin-induced ...
... 1: control (n = 6), group 2: HIPEC with  mitomycin 
A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis
A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis
Pelz, Joerg OW; Doerfer, Joerg; Hohenberger, Werner; Meyer, Thomas
C in a concentration of 15 mg/m2 (n = 6), ...
... cisplatin, 5-fluorouracil, methotrexate,  mitomycin 
Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature
Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature
Coen, Matteo; Rigamonti, Fabio; Roth, Arnaud; Koessler, Thibaud
, and intra-venous bleomycin. ...
... analysis, the cells were dealed with  mitomycin 
Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells
Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells
Yang, Cong-Chong; Zhu, Li-Fang; Xu, Xiao-Hui; Ning, Tian-Yun; Ye, Jin-Hai; Liu, Lai-Kui
at concentration gradients of 16 and 128 ...
... (ifosfamide plus gemcitabine, docetaxel,  mitomycin 
Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer
Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer
Makris, Demosthenes; Scherpereel, Arnaud; Copin, Marie Christine; Colin, Guillaume; Brun, Luc; Lafitte, Jean Jacques; Marquette, Charles Hugo
plus navelbine), followed five months later ...
... has been used, as well as HIPEC using  mitomycin 
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial
Klaver, Charlotte E L; Musters, Gijsbert D; Bemelman, Willem A; Punt, Cornelis J A; Verwaal, Victor J; Dijkgraaf, Marcel GW; Aalbers, Arend GJ; Bilt, Jarmila DW; Boerma, Djamila; Bremers, Andre JA; Burger, Jacobus WA; Buskens, Christianne J; Evers, Pauline; Ginkel, Robert J; Grevenstein, Wilhelmina MU; Hemmer, Patrick HJ; Hingh, Ignace HJT; Lammers, Laureen A; Leeuwen, Barbara L; Meijerink, Wilhelmus JHJ; Nienhuijs, Simon W; Pon, Jolien; Radema, Sandra A; Ramshorst, Bert; Snaebjornsson, Petur; Tuynman, Jurriaan B; Velde, Elisabeth A; Wiezer, Marinus J; Wilt, Johannes HW; Tanis, Pieter J
-C or oxaliplatin [31, 32, 35–38]. ...
... 2 groups; Group (A, n = 10) in which 0.1 mg  mitomycin 
Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol
Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol
Vogl, Thomas J.; Oppermann, Elsie; Qian, Jun; Imlau, Ulli; Tran, Andreas; Hamidavi, Yousef; Korkusuz, Huedayi; Bechstein, Wolf Otto; Nour-Eldin, Nour-Eldin Abdel-Rehim; Gruber-Rouh, Tatjana; Hammerstingl, Renate; Naguib, Nagy Naguib Naeem
, 0.1 ml lipiodol and 5.0 mg degradable ...
... overnight. The cells were treated with  mitomycin 
Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway
Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway
Lee, Cheol-Jung; Lee, Mee-Hyun; Yoo, Sun-Mi; Choi, Kyung-Il; Song, Ji-Hong; Jang, Jeong-Hoon; Oh, Sei-Ryang; Ryu, Hyung-Won; Lee, Hye-Suk; Surh, Young-Joon; Cho, Yong-Yeon
-C (10 μg/ml) for 2 h, and the ...
... in BTC, e.g., fluorouracil, gemcitabine,  mitomycin 
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
Stein, Alexander; Arnold, Dirk; Bridgewater, John; Goldstein, David; Jensen, Lars Henrik; Klümpen, Heinz-Josef; Lohse, Ansgar W.; Nashan, Björn; Primrose, John; Schrum, Silke; Shannon, Jenny; Vettorazzi, Eik; Wege, Henning
, cisplatin, capecitabine, epirubicin, and ...
... FADU and reverseFADU methods [36, 37].  Mitomycin 
Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage
Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage
Pesch, Theresa; Schuhwerk, Harald; Wyrsch, Philippe; Immel, Timo; Dirks, Wilhelm; Bürkle, Alexander; Huhn, Thomas; Beneke, Sascha
C as crosslinking agent showed the expected ...
... Methods Reagents Hoechst 33342 and  Mitomycin 
Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line
Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line
Imai, Misa; Muraki, Miho; Takamatsu, Kiyoshi; Saito, Hidekazu; Seiki, Motoharu; Takahashi, Yuji
C from Streptomyces Caespitosus, ...
... in 1640 containing 10% FBS with or without  mitomycin 
B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells
B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells
Wu, Qiang; Liu, Xue; Yan, Hong; He, Yin-huan; Ye, Shan; Cheng, Xing-wang; Zhu, Gui-lu; Wu, Wen-yong; Wang, Xiao-nan; Kong, Xiang-jun; Xu, Xiao-chun; Lobie, Peter E; Zhu, Tao; Wu, Zheng-sheng
C (10 μg/ml, Sigma, St Louis, MO, USA) to ...
... grown to confluence at which time 10 μg/mL  mitomycin 
APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology
APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology
Odenwald, Matthew A; Prosperi, Jenifer R; Goss, Kathleen H
C (Sigma) was added to inhibit ...
... in DMSO; gemcitabine (GEM) – 10 mM in H2O;  mitomycin 
Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity
Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity
Mezencev, Roman; Matyunina, Lilya V.; Jabbari, Neda; McDonald, John F.
C (MMC) – 10 mM in DMSO; 5-fluorouracil ...

Year Published

 

Country

(see all 38)

Publication


Publication Type


Publisher